LPL Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $272K | Buy |
28,571
+4,091
| +17% | +$31.8K | ﹤0.01% | 5256 |
|
|
2025
Q4 | $191K | Buy |
24,480
+7,467
| +44% | +$54K | ﹤0.01% | 5460 |
|
|
2025
Q3 | $129K | Buy |
17,013
+161
| +1% | +$1.34K | ﹤0.01% | 5453 |
|
|
2025
Q2 | $151K | Buy |
16,852
+2,050
| +14% | +$19.1K | ﹤0.01% | 5170 |
|
|
2025
Q1 | $111K | Buy |
14,802
+870
| +6% | +$7.02K | ﹤0.01% | 5017 |
|
|
2024
Q4 | $105K | Sell |
13,932
-1,940
| -12% | -$14.7K | ﹤0.01% | 4985 |
|
|
2024
Q3 | $121K | Sell |
15,872
-1,760
| -10% | -$13.4K | ﹤0.01% | 4856 |
|
|
2024
Q2 | $109K | Buy |
17,632
+1,215
| +7% | +$6.71K | ﹤0.01% | 4724 |
|
|
2024
Q1 | $83.4K | Sell |
16,417
-1,020
| -6% | -$5.74K | ﹤0.01% | 4705 |
|
|
2023
Q4 | $104K | Sell |
17,437
-1,240
| -7% | -$7.18K | ﹤0.01% | 4542 |
|
|
2023
Q3 | $132K | Sell |
18,677
-10,033
| -35% | -$72.1K | ﹤0.01% | 4360 |
|
|
2023
Q2 | $202K | Buy |
28,710
+1,336
| +5% | +$10.7K | ﹤0.01% | 4147 |
|
|
2023
Q1 | $228K | Buy |
27,374
+3,069
| +13% | +$29.5K | ﹤0.01% | 3944 |
|
|
2022
Q4 | $279K | Buy |
24,305
+2,228
| +10% | +$27.8K | ﹤0.01% | 3699 |
|
|
2022
Q3 | $278K | Buy |
22,077
+818
| +4% | +$10.5K | ﹤0.01% | 3658 |
|
|
2022
Q2 | $225K | Sell |
21,259
-6,075
| -22% | -$62.7K | ﹤0.01% | 3854 |
|
|
2022
Q1 | $444K | Buy |
27,334
+2,464
| +10% | +$39.5K | ﹤0.01% | 3294 |
|
|
2021
Q4 | $344K | Sell |
24,870
-38,595
| -61% | -$511K | ﹤0.01% | 3587 |
|
|
2021
Q3 | $912K | Sell |
63,465
-14,653
| -19% | -$231K | ﹤0.01% | 2684 |
|
|
2021
Q2 | $1.24M | Buy |
78,118
+35,811
| +85% | +$487K | ﹤0.01% | 2392 |
|
|
2021
Q1 | $430K | Buy |
42,307
+22,938
| +118% | +$237K | ﹤0.01% | 3155 |
|
|
2020
Q4 | $144K | Sell |
19,369
-70
| -0.4% | -$361 | ﹤0.01% | 3612 |
|
|
2020
Q3 | $67K | Buy |
+19,439
| New | +$83.3K | ﹤0.01% | 3410 |
|
|
2019
Q3 | – | Sell |
-32,733
| Closed | -$124K | – | 3297 |
|
|
2019
Q2 | $124K | Sell |
32,733
-2,000
| -6% | -$12K | ﹤0.01% | 3133 |
|
|
2019
Q1 | $283K | Buy |
34,733
+1,600
| +5% | +$13.7K | ﹤0.01% | 2691 |
|
|
2018
Q4 | $267K | Sell |
33,133
-1,750
| -5% | -$13.6K | ﹤0.01% | 2561 |
|
|
2018
Q3 | $266K | Sell |
34,883
-1,000
| -3% | -$6.72K | ﹤0.01% | 2788 |
|
|
2018
Q2 | $206K | Buy |
35,883
+2,900
| +9% | +$16K | ﹤0.01% | 2959 |
|
|
2018
Q1 | $157K | Sell |
32,983
-1,675
| -5% | -$8.61K | ﹤0.01% | 3012 |
|
|
2017
Q4 | $170K | Buy |
+34,658
| New | +$168K | ﹤0.01% | 2849 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC